Jane Street Group, LLC Rigel Pharmaceuticals Inc Put Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Feb 15, 2022
SELL
$2.36 - $3.57 $217,120 - $328,440
-92,000 Reduced 87.54%
13,100 $35,000
Q3 2021

Nov 16, 2021
BUY
$3.5 - $4.5 $269,500 - $346,500
77,000 Added 274.02%
105,100 $382,000
Q2 2021

Aug 16, 2021
BUY
$3.09 - $4.54 $86,829 - $127,574
28,100 New
28,100 $122,000

Others Institutions Holding RIGL

# of Institutions
9
Shares Held
334K
Call Options Held
0
Put Options Held
0
View Full List

About RIGEL PHARMACEUTICALS INC

RIGL Quotes by TradingView
  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.81B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email